ConductScience.org, home

Paper494246

Anti-nucleoprotein antibody response in influenza A infection.

Sukeno N and 6 others. Tohoku J Exp Med, 1979. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Anti-nucleoprotein antibody response in influenza A infection. Papers, record 494246. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/494246

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-nucleoprotein antibody response in influenza A infection.
PubMed
Journal
Tohoku J Exp Med
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.56
iCite
Revised in PubMed
2019-07-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sukeno NN
2Otsuki YY
3Konno JJ
4Yamane NN
5Odagiri TT
6Arikawa JJ
7Ishida NN

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Influenza, HumanMajor topic
NucleoproteinsMajor topic
Antigens, Viral
Child, Preschool
Electrophoresis, Polyacrylamide Gel
Humans
Serologic Tests

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42956072Phagocytosis of SARS-CoV-2 nucleocapsid- and RNA-containing immune complexes drives inflammatory cytokine production and endothelial dysfunction.PLoS Pathog2026https://conductscience.org/library/papers/42956072PubMed
36645300Antiviral Approaches against Influenza Virus.Clin Microbiol Rev2023https://conductscience.org/library/papers/36645300PubMed
36128050Evolutionary features of a prolific subtype of avian influenza A virus in European waterfowl.Virus Evol2022https://conductscience.org/library/papers/36128050PubMed
35663997Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response.Front Immunol2022https://conductscience.org/library/papers/35663997PubMed
34067435B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.Viruses2021https://conductscience.org/library/papers/34067435PubMed
30837674The human antibody response to influenza A virus infection and vaccination.Nat Rev Immunol2019https://conductscience.org/library/papers/30837674PubMed
27428437What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.EBioMedicine2016https://conductscience.org/library/papers/27428437PubMed
27354365Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.J Infect Dis2016https://conductscience.org/library/papers/27354365PubMed
26046664Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.PLoS One2015https://conductscience.org/library/papers/26046664PubMed
25876176Progress on adenovirus-vectored universal influenza vaccines.Hum Vaccin Immunother2015https://conductscience.org/library/papers/25876176PubMed
24971078Universal immunity to influenza must outwit immune evasion.Front Microbiol2014https://conductscience.org/library/papers/24971078PubMed
23170167Evasion of influenza A viruses from innate and adaptive immune responses.Viruses2012https://conductscience.org/library/papers/23170167PubMed
22566865Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design.Front Immunol2011https://conductscience.org/library/papers/22566865PubMed
21994606Targets for the induction of protective immunity against influenza a viruses.Viruses2010https://conductscience.org/library/papers/21994606PubMed
21367900Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.J Virol2011https://conductscience.org/library/papers/21367900PubMed
21357542Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus.J Immunol2011https://conductscience.org/library/papers/21357542PubMed
18768874A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.J Immunol2008https://conductscience.org/library/papers/18768874PubMed
6415098Single radial complement fixation test for assaying antibody to influenza virus type-specific antigens.J Clin Microbiol1983https://conductscience.org/library/papers/6415098PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/494246

GET https://conductscience.org/api/papers/v1/494246/authors